Published in J Clin Microbiol on December 01, 1976
Convenient assay for interferons. J Virol (1981) 2.95
Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73
Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13
Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons. J Clin Microbiol (1980) 1.01
Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun (1980) 0.97
Variables affecting viral plaque formation in microculture plaque assays using homologous antibody in a liquid overlay. J Clin Microbiol (1977) 0.86
Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol (1971) 5.90
Microassay for human and chick cell interferons. Appl Microbiol (1968) 4.20
A plaque method for assaying some viruses isolated from common colds. Nature (1961) 2.34
A microplaque reduction assay for human and mouse interferon. Can J Microbiol (1975) 1.95
Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med (1972) 1.79
Rapid sensitive assay for interferons based on the inhibition of MM virus nucleic acid synthesis. Appl Microbiol (1970) 1.77
Unexpectedly rapid action of human interferon in physiological conditions. Nature (1975) 1.41
Dengue virus plaque formation on microplate cultures and its application to virus neutralization (38564). Proc Soc Exp Biol Med (1975) 1.26
Assay of chick interferons by the inhibition of viral ribonucleic acid synthesis. Appl Microbiol (1971) 1.23
Microplaque reduction: new assay for neutralizing antibody to lymphocytic choriomeningitis virus. J Infect Dis (1975) 1.23
Assay of arbovirus neutralizing antibody by micro methods. Trans R Soc Trop Med Hyg (1969) 1.21
The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res (1961) 1.18
Semi-micro XC cell assay technique for murine leukemia virus. Appl Microbiol (1972) 1.18
Interferon assay based on the inhibition of double-stranded reovirus RNA accumulation in mouse L cells. J Gen Virol (1973) 1.17
A chick-embyo cell microtest for typing of Herpesvirus hominis (38531). Proc Soc Exp Biol Med (1975) 1.09
Influence of the rate of cell growth and cell density on interferon action in chick embryo cells. J Virol (1969) 1.00
Interferon bioassay: reduction in yield of myxovirus neuraminidases. J Gen Virol (1973) 0.94
Rapid plaque assay for encephalomyocarditis virus. Appl Microbiol (1969) 0.89
Influence of cell age on production and assay of mouse interferon in L-cells. Arch Gesamte Virusforsch (1970) 0.86
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature (2003) 10.97
The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord (2001) 6.30
Immune specific induction of interferon production in cultures of human blood lymphocytes. Science (1969) 4.43
Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01
Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol (1994) 2.99
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int J Cancer (1966) 2.51
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
The relationship between oxygen consumption and body acceleration in a range of species. Comp Biochem Physiol A Mol Integr Physiol (2008) 2.04
Collaborative physician-patient planning and professional liability: opening the legal door to unconventional medicine. Adv Mind Body Med (1999) 2.04
Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science (1968) 2.02
Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99
Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86. Br J Cancer (1990) 1.85
Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J Immunol (1970) 1.81
Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med (1982) 1.81
Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med (1972) 1.79
High interferon producing line of transformed murine cells. J Gen Virol (1972) 1.79
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis (1973) 1.70
Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Acute appendicitis in children: the importance of family history. J Pediatr Surg (2001) 1.57
Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003. Epidemiol Infect (2007) 1.54
The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A (1965) 1.52
General considerations of the interferon system. Tex Rep Biol Med (1977) 1.52
Systemic lupus erythematosus and lymphoma. Lancet (1978) 1.51
Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells. Cell Immunol (1979) 1.51
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol (2006) 1.49
IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.49
European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine (2003) 1.48
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med (1971) 1.47
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin Oncol (R Coll Radiol) (2004) 1.41
Identification of a subpopulation of mouse lymphoid cells required for interferon production after stimulation with mitogens. J Immunol (1974) 1.41
Unexpectedly rapid action of human interferon in physiological conditions. Nature (1975) 1.41
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol (1988) 1.38
Evaluation of an interferon inducer in viral respiratory disease. JAMA (1972) 1.37
Event excess in the MiniBooNE search for ¯νμ→¯νe oscillations. Phys Rev Lett (2010) 1.37
Accelerometry to Estimate Energy Expenditure during Activity: Best Practice with Data Loggers. Physiol Biochem Zool (2009) 1.37
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res (1984) 1.35
Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature (1976) 1.35
Anaphylactic reaction to streptokinase with first exposure: case report and review of the literature. DICP (1989) 1.34
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Adaptive diversification within a large family of recently duplicated, placentally expressed genes. Proc Natl Acad Sci U S A (2000) 1.32
Interferon-induced transfer of viral resistance between animal cells. Nature (1977) 1.31
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene (2010) 1.31
Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide. J Exp Med (1972) 1.30
Effect of interferon on early interferon production. Science (1966) 1.30
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Sensitivity of common respiratory viruses to an interferon inducer in human cells. Lancet (1969) 1.29
Growth of Toxoplasma gondii in various tissue cultures treated with In-Cn or interferon. Proc Soc Exp Biol Med (1973) 1.26
Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer (2007) 1.25
Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24
Characterization of the airborne concentrations of lead in U.S. industry. Am J Ind Med (1990) 1.23
Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23
Effects of interferon inducers on the intracellular growth of the protozoan parasite, Leishmania donovani. Nature (1970) 1.23
Epileptic seizures associated with cisplatin administration. Cancer Treat Rep (1982) 1.22
Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice. Proc Soc Exp Biol Med (1970) 1.22
Hmx2 homeobox gene control of murine vestibular morphogenesis. Development (2001) 1.22
Automated, quantitative cytopathic effect reduction assay for interferon. J Clin Microbiol (1982) 1.22
The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol (1976) 1.21
Three strains of influenza A virus (H3N2): interferon sensitivity in vitro and interferon production in volunteers. J Clin Microbiol (1976) 1.21
Presence of interferon in acute- and convalescent-phase sera of humans with influenza or influenza-like illness of undetermined etiology. J Infect Dis (1982) 1.21
Sequential production of IFN-alpha and immune-specific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus. J Immunol (1981) 1.20
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus. Infect Immun (1975) 1.19
Antiviral action of mouse interferon in heterologous cells. J Bacteriol (1966) 1.19
Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 1.19
Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. J Infect Dis (1980) 1.18
[Evaluation of tracheobronchial lesions with spiral CT: comparison between virtual endoscopy and bronchoscopy]. Radiol Med (2002) 1.17
Interleukin 2 enhances natural killing of normal lymphocytes. Cell Immunol (1984) 1.17
Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon. J Virol (1969) 1.16
IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis. J Immunol (1995) 1.16
Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: single or combination chemotherapy? BJOG (2010) 1.15
Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex. Proc Natl Acad Sci U S A (1969) 1.14
Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst (1980) 1.14
Definition and classification of the interferons. Methods Enzymol (1981) 1.14
Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection. Infect Immun (1983) 1.13
Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13
Virus yield-reduction assay for interferon by titration of Sindbis virus hemagglutinin. Methods Enzymol (1981) 1.12
Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol (1982) 1.12
Broadly active inhibitor of viruses spontaneously produced by many cell types in culture. Infect Immun (1981) 1.12
Rubella virus: role of interferon during infection of African green monkey kidney tissue cultures. J Immunol (1967) 1.12
Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol (2000) 1.12
Transcriptional profiling of pig embryogenesis by using a 15-K member unigene set specific for pig reproductive tissues and embryos. Biol Reprod (2005) 1.11
The effect of an interferon inducer on influenza virus. Bull World Health Organ (1969) 1.10
Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol (1999) 1.09